Variant report

Variant	esv3390027
Chromosome Location	chr21:47396749-47399297
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr21:47397006-47397624	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr21:47397380-47397530	AG04449	skin:	n/a	n/a
3	CTCF	chr21:47397406-47397463	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr21:47399280-47399430	WERI-Rb-1	eye:	n/a	chr21:47399353-47399361
5	CTCF	chr21:47397460-47397610	HA-sp	spinal cord:	n/a	n/a
6	CTCF	chr21:47399240-47399390	Caco-2	colon:	n/a	chr21:47399353-47399361
7	CTCF	chr21:47399260-47399410	HEK293	kidney:	n/a	chr21:47399353-47399361
8	EP300	chr21:47397228-47397714	ECC-1	luminal epithelium:	n/a	n/a
9	FOS	chr21:47399109-47399126	MCF10A-Er-Src	breast:	n/a	n/a
10	FOS	chr21:47399108-47399111	MCF10A-Er-Src	breast:	n/a	n/a
11	FOSL2	chr21:47398969-47399292	HepG2	liver:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
12	HMGN3	chr21:47399194-47399292	K562	blood:	n/a	n/a
13	JUND	chr21:47399073-47399203	K562	blood:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399102-47399113 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
14	JUND	chr21:47399054-47399186	HepG2	liver:	n/a	chr21:47399103-47399113 chr21:47399104-47399112 chr21:47399102-47399113 chr21:47399103-47399113 chr21:47399103-47399113 chr21:47399105-47399112 chr21:47399100-47399111 chr21:47399104-47399112 chr21:47399103-47399113
15	MAZ	chr21:47397323-47398871	IMR90	lung:	n/a	chr21:47398447-47398456
16	MAZ	chr21:47398161-47398490	K562	blood:	n/a	chr21:47398447-47398456
17	POLR2A	chr21:47397016-47397095	H1-hESC	embryonic stem cell:	n/a	n/a
18	RAD21	chr21:47397469-47397580	H1-hESC	embryonic stem cell:	n/a	n/a
19	RAD21	chr21:47399274-47399474	H1-hESC	embryonic stem cell:	n/a	chr21:47399353-47399362
20	REST	chr21:47397438-47397662	SK-N-SH	brain:	n/a	n/a
21	SIN3A	chr21:47396968-47397640	H1-hESC	embryonic stem cell:	n/a	chr21:47397312-47397320
22	TBP	chr21:47397397-47397555	H1-hESC	embryonic stem cell:	n/a	n/a
23	USF2	chr21:47397456-47397475	H1-hESC	embryonic stem cell:	n/a	n/a
24	ZBTB7A	chr21:47399102-47399257	K562	blood:	n/a	n/a
25	ZNF143	chr21:47396982-47397994	H1-hESC	embryonic stem cell:	n/a	n/a
26	ZNF263	chr21:47399291-47399348	HEK293-T-REx	kidney:	n/a	n/a
27	ZNF263	chr21:47398040-47398688	HEK293-T-REx	kidney:	n/a	chr21:47398303-47398324 chr21:47398261-47398282
28	ZNF263	chr21:47396960-47397179	HEK293-T-REx	kidney:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr21:47398596-47398646	CMK	blood:	n/a
2	chr21:47398596-47398646	K562	blood:	n/a
3	chr21:47396773-47396823	MCF10A-Er-Src	breast:	n/a
4	chr21:47398596-47398646	GM19239	blood:	n/a
5	chr21:47398596-47398646	PANC-1	pancreas:	n/a
6	chr21:47396773-47396823	AG09309	skin:	n/a
7	chr21:47398596-47398646	LNCaP	prostate:	n/a
8	chr21:47398596-47398646	MCF-7	breast:	n/a
9	chr21:47398596-47398646	HCM	heart:	n/a
10	chr21:47396773-47396823	NHBE	bronchial:	n/a
11	chr21:47396773-47396823	GM06990	blood:	n/a
12	chr21:47398596-47398646	U87	brain:	n/a
13	chr21:47398596-47398646	RPTEC	kidney:	n/a
14	chr21:47396773-47396823	HRPEpiC	eye:	n/a
15	chr21:47396773-47396823	HRCEpiC	kidney:	n/a
16	chr21:47398596-47398646	HCPEpiC	choroid plexus:	n/a
17	chr21:47396773-47396823	AoSMC	blood vessel:	n/a
18	chr21:47396773-47396823	NB4	blood:	n/a
19	chr21:47398596-47398646	GM12892	blood:	n/a
20	chr21:47396773-47396823	AG04449	skin:	fetal
21	chr21:47396773-47396823	HNPCEpiC	eye:	n/a
22	chr21:47398596-47398646	PFSK-1	brain:	n/a
23	chr21:47398596-47398646	AG09309	skin:	n/a
24	chr21:47396773-47396823	A549	lung:	n/a
25	chr21:47398596-47398646	NB4	blood:	n/a
26	chr21:47398596-47398646	Jurkat	blood:	n/a
27	chr21:47398596-47398646	HRPEpiC	eye:	n/a
28	chr21:47398596-47398646	SK-N-SH_RA	brain:	n/a
29	chr21:47396773-47396823	HMEC	breast:	n/a
30	chr21:47398596-47398646	AG09319	gingival:	n/a
31	chr21:47396773-47396823	ECC-1	luminal epithelium:	n/a
32	chr21:47396773-47396823	HAEpiC	amniotic membrane:	n/a
33	chr21:47396773-47396823	SK-N-MC	brain:	n/a
34	chr21:47398596-47398646	IMR90	lung:	fetal
35	chr21:47396773-47396823	HPAEpiC	pulmonary alveolar:	n/a
36	chr21:47396773-47396823	HCT-116	colon:	n/a
37	chr21:47398596-47398646	HRCEpiC	kidney:	n/a
38	chr21:47398596-47398646	Hela-S3	cervix:	n/a
39	chr21:47396773-47396823	HEK293	kidney:	embryo
40	chr21:47398596-47398646	HCF	heart:	n/a
41	chr21:47398596-47398646	HCT-116	colon:	n/a
42	chr21:47396773-47396823	K562	blood:	n/a
43	chr21:47396773-47396823	HRE	kidney:	n/a
44	chr21:47396773-47396823	RPTEC	kidney:	n/a
45	chr21:47396773-47396823	H1-hESC	embryonic stem cell:	embryo
46	chr21:47398596-47398646	SKMC	muscle:	n/a
47	chr21:47398596-47398646	Hepatocyte	liver:	n/a
48	chr21:47396773-47396823	NH-A	brain:	n/a
49	chr21:47396773-47396823	HEEpiC	esophagus:	n/a
50	chr21:47396773-47396823	NT2-D1	testis:	n/a

No.	Distal block	Cell Line	Cell type
1	chr21:47384997..47386531-chr21:47397126..47399086,2	MCF-7	breast:
2	chr21:47389572..47393249-chr21:47393676..47397258,4	K562	blood:
3	chr21:47388213..47390098-chr21:47396842..47399384,2	MCF-7	breast:
4	chr21:47393205..47395473-chr21:47397498..47399697,5	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-COL6A1-4	chr21:47399121-47399441	NONHSAT083005
2	lnc-COL6A1-4	chr21:47398531-47398625	NONHSAT083005
3	lnc-FTCD-2	chr21:47397451-47397653	XLOC_014129
4	lnc-COL6A1-4	chr21:47397218-47397295	NONHSAT083005

Variant related genes	Relation type
COL6A1	TF binding region
COL6A1	CpG island
AFF4	miRNA target sites

Extended variants
information (count: 106 )
Associated
traits (count: 36 )

Variant overlapped rSNPs/rCNVs (count:106 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs571018966	chr21:47396843-47396844	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs538201767	chr21:47396845-47396846	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs561892333	chr21:47396876-47396877	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs575489023	chr21:47396899-47396900	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs145677591	chr21:47396918-47396919	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs527686203	chr21:47396977-47396978	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs186222361	chr21:47396989-47396990	Weak transcription Bivalent/Poised TSS Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs116587309	chr21:47397026-47397027	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs533969336	chr21:47397041-47397042	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs149793500	chr21:47397070-47397071	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs191973430	chr21:47397161-47397162	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs199965445	chr21:47397169-47397170	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs540436187	chr21:47397181-47397182	Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs60864463	chr21:47397208-47397209	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs57301453	chr21:47397215-47397216	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs57075267	chr21:47397217-47397218	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs56905329	chr21:47397223-47397224	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
18	rs12483362	chr21:47397225-47397226	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
19	rs374980427	chr21:47397238-47397239	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
20	rs537713352	chr21:47397252-47397253	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
21	rs545416800	chr21:47397312-47397313	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs181845167	chr21:47397319-47397320	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs538168549	chr21:47397356-47397357	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs531219126	chr21:47397395-47397396	Weak transcription Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs557691322	chr21:47397400-47397401	Weak transcription Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs186906097	chr21:47397415-47397416	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs191198357	chr21:47397468-47397469	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs7275644	chr21:47397525-47397526	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs546794334	chr21:47397555-47397556	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs1883048	chr21:47397586-47397587	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs571878911	chr21:47397588-47397589	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
32	rs538390005	chr21:47397590-47397591	Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
33	rs556526149	chr21:47397622-47397623	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
34	rs77215405	chr21:47397722-47397723	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs78615502	chr21:47397724-47397725	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs9980553	chr21:47397727-47397728	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs76573695	chr21:47397729-47397730	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs9979446	chr21:47397735-47397736	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs151233285	chr21:47397773-47397774	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs568790032	chr21:47397805-47397806	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs117775279	chr21:47397828-47397829	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	mRNA abundance
42	rs117179421	chr21:47397867-47397868	Weak transcription Enhancers Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs200825536	chr21:47398001-47398002	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs373986375	chr21:47398058-47398059	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs567961613	chr21:47398096-47398097	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs573099935	chr21:47398111-47398112	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs533825716	chr21:47398117-47398118	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs11910769	chr21:47398149-47398150	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs11910668	chr21:47398152-47398153	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs11910685	chr21:47398162-47398163	Weak transcription Enhancers ZNF genes & repeats Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:36)

Disease	PMID	Source
Down syndrome	17576883	CNVD
Acute promyelocytic leukemia	19109227	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Autism	22958593	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Autism	18414403	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Breast cancer	17899364	CNVD
Prostate cancer	20473283	CNVD
Chordoma	18071362	CNVD
Cholangiocarcinoma	16830362	CNVD
Down syndrome	17334655	CNVD
Neuroticism	17667963	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Autoimmune polyendocrine syndrome	18200029	CNVD
Prostate cancer	19363497	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Olfactory neuroblastoma	18408657	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Multiple myeloma	16616336	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:211 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr21:47392400-47396800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
2	chr21:47392400-47397600	Active TSS	iPS-15b Cell Line	embryonic stem cell
3	chr21:47392800-47397600	Active TSS	HUES48 Cell Line	embryonic stem cell
4	chr21:47394400-47400400	Weak transcription	Pancreatic Islets	Pancreatic Islet
5	chr21:47394800-47400800	Weak transcription	Pancreas	Pancrea
6	chr21:47395000-47397400	Active TSS	HUES6 Cell Line	embryonic stem cell
7	chr21:47395000-47398400	Weak transcription	Brain Substantia Nigra	brain
8	chr21:47395000-47400600	Weak transcription	Dnd41	blood
9	chr21:47395000-47401000	Enhancers	Fetal Muscle Leg	muscle
10	chr21:47395200-47400600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
11	chr21:47395200-47400800	Weak transcription	Left Ventricle	heart
12	chr21:47395200-47401000	Weak transcription	Gastric	stomach
13	chr21:47395200-47401000	Weak transcription	HSMMtube	muscle
14	chr21:47395400-47396800	Active TSS	ES-I3 Cell Line	embryonic stem cell
15	chr21:47395400-47397000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr21:47395400-47397000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
17	chr21:47395400-47397200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr21:47395400-47397200	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
19	chr21:47395400-47397200	Weak transcription	Ovary	ovary
20	chr21:47395400-47397400	Weak transcription	NHDF-Ad	bronchial
21	chr21:47395400-47398000	Weak transcription	Fetal Heart	heart
22	chr21:47395400-47398200	Weak transcription	Muscle Satellite Cultured Cells	--
23	chr21:47395400-47398200	Weak transcription	Osteobl	bone
24	chr21:47395400-47398400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
25	chr21:47395400-47398600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
26	chr21:47395400-47400600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
27	chr21:47395400-47400600	Weak transcription	Adipose Nuclei	Adipose
28	chr21:47395400-47400800	Weak transcription	Right Atrium	heart
29	chr21:47395400-47400800	Weak transcription	HSMM	muscle
30	chr21:47395400-47401000	Weak transcription	HMEC	breast
31	chr21:47395600-47397400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
32	chr21:47395600-47397400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
33	chr21:47395600-47397400	Weak transcription	NH-A	brain
34	chr21:47395600-47397400	Weak transcription	NHLF	lung
35	chr21:47395600-47401000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr21:47395800-47397800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr21:47396000-47396800	Enhancers	Placenta Amnion	Placenta Amnion
38	chr21:47396000-47397200	Weak transcription	Rectal Smooth Muscle	rectum
39	chr21:47396000-47397200	Weak transcription	Stomach Smooth Muscle	stomach
40	chr21:47396200-47397400	Weak transcription	Colon Smooth Muscle	Colon
41	chr21:47396600-47396800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
42	chr21:47396600-47396800	Flanking Active TSS	H9 Cell Line	embryonic stem cell
43	chr21:47396600-47396800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
44	chr21:47396600-47396800	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
45	chr21:47396600-47396800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
46	chr21:47396600-47396800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr21:47396600-47396800	Enhancers	Breast Myoepithelial Primary Cells	Breast
48	chr21:47396600-47396800	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
49	chr21:47396600-47396800	Flanking Bivalent TSS/Enh	Colonic Mucosa	Colon
50	chr21:47396600-47396800	Bivalent Enhancer	Stomach Mucosa	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links